Collaborations & Alliances
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Servier & Harvard Partner for Diabetes
Three year collaboration will focus on exploring a new avenue for the treatment of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)03.21.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Domainex & SpiroChem Enter Discovery Collaboration
Domainex will enrich its existing fragment collection with a diverse set of SpiroChem fragments that it will screen with its FragmentBuilder platform03.21.19
-
Breaking News | Collaborations & Alliances | Industry News
Alvogen Investment Bolsters Asian Presence
Enters cross-investment partnership with Fuji to enhance market access to fast-growing Asian pharma market03.21.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Preclinical Outsourcing | Process Development
WuXi STA Forms Partnership with Beta Pharma
STA will accelerate process R&D and manufacturing of late phase and commercial targets03.21.19
-
Breaking News | Collaborations & Alliances | Drug Development
Takeda, HemoShear Expand NASH Pact
Several drug targets shown to inhibit biological processes associated with inflammation and fibrosis that can lead to nonalcoholic steatohepatitis03.20.19
-
APIs | Breaking News | Collaborations & Alliances | Industry News
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer
VGXI Achieves Tech Transfer Milestones
Relates to RNA manufacturing partnership with research inst. in Houston03.19.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Pall Enters Cell and Gene Therapy Mfg. Tie-up with NJII
Will invest $3.5 million in new innovation partnership03.19.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances
MilliporeSigma, GenScript to Accelerate Cell and Gene Therapy Industrialization in China
Collaboration to build global-standard platform for plasmid and virus manufacturing in China03.19.19
-
Collaborations & Alliances | Drug Development | Drug Discovery
AbCellera Inks $4.8M Global Research Pact
Contract with the Gates foundation to develop antibody therapeutics and preventative vaccines for infectious diseases, including HIV, malaria, and tuberculosisOnline Exclusives03.15.19
-
Bio News | Collaborations & Alliances | Industry News | R&D
Servier & Oncodesign Partner for Parkinson's
R&D partnership involves the LRRK2 kinase inhibitors derived from Oncodesign's proprietary Nanocyclix platform, and their potential to act against Parkinson's03.14.19
-
Breaking News | Collaborations & Alliances | Drug Discovery | Information Technology
Merck KGaA, Iktos Enter AI Discovery Partnership
Collaboration gives Merck KGaA access to Iktos AI technology across three drug discovery projects03.14.19
-
Bio News | Collaborations & Alliances | Formulation Development | Industry News | R&D
Rosa & Co. & Chugai Enter Research Agreement
For Rosa's PhysioPD research services, which will provide Chugai with a competitive research and development advantage across multiple therapeutic areas03.14.19
-
Breaking News | Collaborations & Alliances | Drug Development
Agenus Milestone Triggers $7.5M Payment from Gilead
FDA has accepted IND filing for AGEN142303.14.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Injectables
SunGen, Athenex Launch Busulfan Injection
Ownership transferred from Sandoz to the companies, with 2018 US Sales topping $33.6M according to IQVIA data03.14.19
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Industry News
Aldevron Releases GMP-Grade SpyFi Cas9 Nuclease
Advantages of SpyFi Cas9 Nuclease include reduced off-target effects combined with clinically relevant on-target activity03.14.19
-
Breaking News | Collaborations & Alliances | Drug Development
TaiwanJ Inks $26M Deal with Newsoara
For licensing and co-development contract with Newsoara on JKB-122 Asian rights03.12.19
-
Bio News | Breaking News | Collaborations & Alliances | R&D
AstraZeneca, Seres in Cancer Research Tie-up
Seres to receive $20 million and financial support for research activities03.12.19
-
Breaking News | Collaborations & Alliances | Drug Discovery
Crown Bio, Charles River Enter Discovery Agreement
Enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome03.12.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Process Validation | Scale-up/Technology Transfer
3P Enters Mfg. Tie-up With Dutch Biotech Xenikos
3P responsible for process transfer and scale-up, cGMP production for clinical trials and process validation03.12.19
